COMP <GO>
TFX vs MRK // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Teleflex Incorporated (NYSE) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: TFX 3
— MRK 12
▲ OPTIONS IMPLIED MOVE & PUT/CALL SKEW LEADER: MRK
LAST: $139.77 (-1.15%) • MKT CAP: $5.99B
options-implied-move
6.80%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
options-implied-move
6.60%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TFX VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TFX | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 56.20% | 74.80% | -18.60 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 1.80% | 20.70% | -18.90 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 40.9x | 15.3x | +25.60 | MRK | /valuation <GO> |
| Free Cash Flow Yield | -18.00% | 3.42% | -21.42 | MRK | /fcf-yield <GO> |
| Operating Margin | 5.90% | 34.30% | -28.40 | MRK | /operating-margins <GO> |
| Net Profit Margin | -45.40% | 28.10% | -73.50 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 17.20% | 1.30% | +15.90 | TFX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.01% | 2.26% | -1.25 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.12 | 5.19 | -3.07 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | 6.80% | 6.60% | +0.20 | MRK | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 67.9 | 56.9 | +11.06 | TFX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.98 | 0.92 | +0.06 | TFX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 27.0x | 18.4x | +8.60 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.99B | $361.02B | -$355.03B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TFX REV | MRK REV | TFX GROSS % | MRK GROSS % | TFX FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.99B | $65.01B | 56.2% | 74.8% | -$1.11B | $12.36B |
| FY 2024 | $1.70B | $64.17B | 61.0% | 76.3% | -$11.9M | $18.10B |
| FY 2023 | $1.71B | $60.12B | 44.0% | 44.0% | $323.4M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TFX // BETA 0.98
MRK // BETA 0.92